Water-Soluble C60 Protects Against Bleomycin-Induced Pulmonary Fibrosis in Mice

Run Dong,1,2,* Min Liu,3,* Xiao-Xi Huang,4 Zheng Liu,4 Ding-Yuan Jiang,5 Hui-Juan Xiao,1 Jing Geng,5 Yan-Hong Ren,5 Hua-Ping Dai5 1Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders, Department of Respiratory Medicine, Capital Medical University, Beijing, People’s Re...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dong R, Liu M, Huang XX, Liu Z, Jiang DY, Xiao HJ, Geng J, Ren YH, Dai HP
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/7d371259137a4486bf4ad57c87a132f0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7d371259137a4486bf4ad57c87a132f0
record_format dspace
spelling oai:doaj.org-article:7d371259137a4486bf4ad57c87a132f02021-12-02T08:48:08ZWater-Soluble C60 Protects Against Bleomycin-Induced Pulmonary Fibrosis in Mice1178-2013https://doaj.org/article/7d371259137a4486bf4ad57c87a132f02020-03-01T00:00:00Zhttps://www.dovepress.com/water-soluble-c60-protects-against-bleomycin-induced-pulmonary-fibrosi-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Run Dong,1,2,* Min Liu,3,* Xiao-Xi Huang,4 Zheng Liu,4 Ding-Yuan Jiang,5 Hui-Juan Xiao,1 Jing Geng,5 Yan-Hong Ren,5 Hua-Ping Dai5 1Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders, Department of Respiratory Medicine, Capital Medical University, Beijing, People’s Republic of China; 2Department of Respiratory Medicine, Zhengzhou Central Hospital, Zhengzhou, People’s Republic of China; 3Department of Radiology, China-Japan Friendship Hospital, Beijing, People’s Republic of China; 4Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders, Department of Medical Research, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People’s Republic of China; 5Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital; National Clinical Research Center for Respiratory Diseases; Capital Medical University, Beijing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Hua-Ping DaiDepartment of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, People’s Republic of ChinaEmail daihuaping@ccmu.edu.cnBackground: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic interstitial pneumonia. And, oxidation/antioxidant imbalance plays an important role in the progress of IPF. Fullerene is considered to be a novel “structural” antioxidant. This study aimed to explore if water-soluble C60 (C60(OH)22) can exhibit antifibrotic activity in its antioxidant role.Methods: Healthy C57BL/6J mice were randomly grouped and induced pulmonary fibrosis by intratracheal injection of bleomycin.Results: The survival rate of mice was observed and found that 10mg/kg was the optimal dose of water-soluble C60 for pulmonary fibrosis. We observed that water-soluble C60 can alleviate the severity of pulmonary fibrosis by observing the chest computed tomography, pulmonary pathology, and content of collagen, alpha smooth muscle actin and fibronectin in lung. Compared with bleomycin group, ROS, the content of TNF-α in BALF, and the number of fibroblasts was significantly decreased and the number of type Ⅱ alveolar epithelial cells was increased after treatment with C60.Conclusion: Therefore, thanks to its powerful antioxidant action, water-soluble C60 can reduce the severity of pulmonary fibrosis induced by bleomycin in mice.Keywords: pulmonary fibrosis, bleomycin, water-soluble C60, miceDong RLiu MHuang XXLiu ZJiang DYXiao HJGeng JRen YHDai HPDove Medical Pressarticlepulmonary fibrosisbleomycinwater-soluble c60miceMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 2269-2276 (2020)
institution DOAJ
collection DOAJ
language EN
topic pulmonary fibrosis
bleomycin
water-soluble c60
mice
Medicine (General)
R5-920
spellingShingle pulmonary fibrosis
bleomycin
water-soluble c60
mice
Medicine (General)
R5-920
Dong R
Liu M
Huang XX
Liu Z
Jiang DY
Xiao HJ
Geng J
Ren YH
Dai HP
Water-Soluble C60 Protects Against Bleomycin-Induced Pulmonary Fibrosis in Mice
description Run Dong,1,2,* Min Liu,3,* Xiao-Xi Huang,4 Zheng Liu,4 Ding-Yuan Jiang,5 Hui-Juan Xiao,1 Jing Geng,5 Yan-Hong Ren,5 Hua-Ping Dai5 1Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders, Department of Respiratory Medicine, Capital Medical University, Beijing, People’s Republic of China; 2Department of Respiratory Medicine, Zhengzhou Central Hospital, Zhengzhou, People’s Republic of China; 3Department of Radiology, China-Japan Friendship Hospital, Beijing, People’s Republic of China; 4Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders, Department of Medical Research, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People’s Republic of China; 5Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital; National Clinical Research Center for Respiratory Diseases; Capital Medical University, Beijing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Hua-Ping DaiDepartment of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, People’s Republic of ChinaEmail daihuaping@ccmu.edu.cnBackground: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic interstitial pneumonia. And, oxidation/antioxidant imbalance plays an important role in the progress of IPF. Fullerene is considered to be a novel “structural” antioxidant. This study aimed to explore if water-soluble C60 (C60(OH)22) can exhibit antifibrotic activity in its antioxidant role.Methods: Healthy C57BL/6J mice were randomly grouped and induced pulmonary fibrosis by intratracheal injection of bleomycin.Results: The survival rate of mice was observed and found that 10mg/kg was the optimal dose of water-soluble C60 for pulmonary fibrosis. We observed that water-soluble C60 can alleviate the severity of pulmonary fibrosis by observing the chest computed tomography, pulmonary pathology, and content of collagen, alpha smooth muscle actin and fibronectin in lung. Compared with bleomycin group, ROS, the content of TNF-α in BALF, and the number of fibroblasts was significantly decreased and the number of type Ⅱ alveolar epithelial cells was increased after treatment with C60.Conclusion: Therefore, thanks to its powerful antioxidant action, water-soluble C60 can reduce the severity of pulmonary fibrosis induced by bleomycin in mice.Keywords: pulmonary fibrosis, bleomycin, water-soluble C60, mice
format article
author Dong R
Liu M
Huang XX
Liu Z
Jiang DY
Xiao HJ
Geng J
Ren YH
Dai HP
author_facet Dong R
Liu M
Huang XX
Liu Z
Jiang DY
Xiao HJ
Geng J
Ren YH
Dai HP
author_sort Dong R
title Water-Soluble C60 Protects Against Bleomycin-Induced Pulmonary Fibrosis in Mice
title_short Water-Soluble C60 Protects Against Bleomycin-Induced Pulmonary Fibrosis in Mice
title_full Water-Soluble C60 Protects Against Bleomycin-Induced Pulmonary Fibrosis in Mice
title_fullStr Water-Soluble C60 Protects Against Bleomycin-Induced Pulmonary Fibrosis in Mice
title_full_unstemmed Water-Soluble C60 Protects Against Bleomycin-Induced Pulmonary Fibrosis in Mice
title_sort water-soluble c60 protects against bleomycin-induced pulmonary fibrosis in mice
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/7d371259137a4486bf4ad57c87a132f0
work_keys_str_mv AT dongr watersolublec60protectsagainstbleomycininducedpulmonaryfibrosisinmice
AT lium watersolublec60protectsagainstbleomycininducedpulmonaryfibrosisinmice
AT huangxx watersolublec60protectsagainstbleomycininducedpulmonaryfibrosisinmice
AT liuz watersolublec60protectsagainstbleomycininducedpulmonaryfibrosisinmice
AT jiangdy watersolublec60protectsagainstbleomycininducedpulmonaryfibrosisinmice
AT xiaohj watersolublec60protectsagainstbleomycininducedpulmonaryfibrosisinmice
AT gengj watersolublec60protectsagainstbleomycininducedpulmonaryfibrosisinmice
AT renyh watersolublec60protectsagainstbleomycininducedpulmonaryfibrosisinmice
AT daihp watersolublec60protectsagainstbleomycininducedpulmonaryfibrosisinmice
_version_ 1718398372061118464